FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arto Leminen

Research Profile

Disorders

Concepts & Ideas

Geographic Areas

Finland

Chemicals & Drugs

Procedures

Immunohistochemistry

Co-author Network

Publications

TOP 3
Anna Luomaranta; Arto Leminen; Mikko Loukovaara
Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor histology.
Vedran Stefanovic; Ulf-Håkan Stenman; Henrik Alfthan; Arto Leminen; Päivi Pakarinen; Jurate Pociuviene; Annika Riska; Mikko Loukovaara
Erythropoietin is detectable in the ascitic fluid in patients with ovarian tumors.
Liisa M Pelttari; Johanna Schleutker; Riikka Nurminen; Lauri A Aaltonen; Kristiina Aittomäki; Carl Blomqvist; Ralf Bützow; Alexandra Gylfe; Päivi Heikkilä; Anne Kallioniemi; Johanna Kiiski; Arto Leminen; Heli Nevanlinna
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arto Leminen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anna Luomaranta; Arto Leminen; Mikko Loukovaara
Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor histology.
Gynecologic oncology 2013;129(1):28-32.
2012: Vedran Stefanovic; Ulf-Håkan Stenman; Henrik Alfthan; Arto Leminen; Päivi Pakarinen; Jurate Pociuviene; Annika Riska; Mikko Loukovaara
Erythropoietin is detectable in the ascitic fluid in patients with ovarian tumors.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012;22(9):1470-3.
2012: Liisa M Pelttari; Johanna Schleutker; Riikka Nurminen; Lauri A Aaltonen; Kristiina Aittomäki; Carl Blomqvist; Ralf Bützow; Alexandra Gylfe; Päivi Heikkilä; Anne Kallioniemi; Johanna Kiiski; Arto Leminen; Heli Nevanlinna
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer.
Journal of medical genetics 2012;49(7):429-32.
2012: R Koivisto-Korander; Arto Leminen; J I Martinsen; ELISABETE WEIDERPASS; E Pukkala
Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases.
Maturitas 2012;72(1):56-60.
2012: Arto Leminen; Johanna Mäenpää; Ulla Puistola; Maarit Vuento; Piia Vuorela; Annika Auranen; Ralf Bützow; Sakari Hietanen; Marja Komulainen; Tapio Kuoppala; Merja Yliskoski
[Update on current care guidelines: ovarian cancer].
Duodecim; lääketieteellinen aikakauskirja 2012;128(12):1300-1.
2011: Anniina Färkkilä; Markku Heikinheimo; Arto Leminen; Marjut Pihlajoki; Hanna Tauriala; Leila Unkila-Kallio; Ralf Bützow; Mikko Anttonen
Serum vascular endothelial growth factor A (VEGF) is elevated in patients with ovarian granulosa cell tumor (GCT), and VEGF inhibition by bevacizumab induces apoptosis in GCT in vitro.
The Journal of clinical endocrinology and metabolism 2011;96(12):E1973-81.
2011: Anna-Liisa Kautio; Arto Leminen; Maija Haanpää; Eija Kalso; Hannu Kautiainen; Tiina Saarto
Oxaliplatin scale and National Cancer Institute-Common Toxicity Criteria in the assessment of chemotherapy-induced peripheral neuropathy.
Anticancer research 2011;31(10):3493-6.
2011: C Böckelman; Ralf Bützow; Caj Haglund; Annabrita Hemmes; Heini Lassus; Arto Leminen; Jukka Westermarck; Ari Ristimäki
Prognostic role of CIP2A expression in serous ovarian cancer.
British journal of cancer 2011;105(7):989-95.
2011: Riitta Koivisto-Korander; Ralf Butzow; Anna-Maija Koivisto; Arto Leminen
Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2011;32(3):451-9.
2011: Anniina Färkkilä; Mikko Anttonen; Jurate Pociuviene; Arto Leminen; Ralf Butzow; Markku Heikinheimo; Leila Unkila-Kallio
Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
European journal of endocrinology / European Federation of Endocrine Societies 2011;164(1):115-22.
2011: Heini Lassus; Synnöve Staff; Arto Leminen; Jorma Isola; Ralf Butzow
Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma.
Gynecologic oncology 2011;120(1):11-7.
2009: Salla Kumpulainen; Risto Sankila; Arto Leminen; Tapio Kuoppala; Marja Komulainen; Ulla Puistola; Saija Hurme; Heikki Hiekkanen; Juha Mäkinen; Seija Grénman
The effect of hospital operative volume, residual tumor and first-line chemotherapy on survival of ovarian cancer - a prospective nation-wide study in Finland.
Gynecologic oncology 2009;115(2):199-203.
2009: Anna-Liisa Kautio; Maija Haanpää; Arto Leminen; Eija Kalso; Hannu Kautiainen; Tiina Saarto
Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
Anticancer research 2009;29(7):2601-6.
2009: Johanna Mäenpää; Arto Leminen
Biweekly docetaxel in recurrent ovarian cancer: a phase I dose finding study.
Cancer chemotherapy and pharmacology 2009;64(2):297-300.
2009: Kaisa Taipale; Arto Leminen; Pirjo Räsänen; Anne Heikkilä; Anna-Maija Tapper; Harri Sintonen; Risto P Roine
Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders.
Acta obstetricia et gynecologica Scandinavica 2009;88(12):1402-10.
2008: Antti Kyrönlahti; Maarit Rämö; Maija Tamminen; Leila Unkila-Kallio; Ralf Butzow; Arto Leminen; Mona Nemer; Nafis Rahman; Ilpo Huhtaniemi; Markku Heikinheimo; Mikko Anttonen
GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors.
Endocrinology 2008;149(11):5635-42.
2008: Riitta Koivisto-Korander; Ralf Butzow; Anna-Maija Koivisto; Arto Leminen
Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Gynecologic oncology 2008;111(1):74-81.
2008: Jonna Salonen; Arto Leminen; Ulf-Hakan Stenman; Ralf Butzow; Markku Heikinheimo; Oskari Heikinheimo
Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2008;29(1):50-6.
2007: Annika Riska; Patrik Finne; P Koskela; Henrik Alfthan; Jyrki Jalkanen; M Lehtinen; T Sorvari; Ulf-Hakan Stenman; Jorma Paavonen; Arto Leminen
Human papillomavirus infection and primary fallopian tube carcinoma: a seroepidemiological study.
BJOG : an international journal of obstetrics and gynaecology 2007;114(4):425-9.
2007: Annika Riska; Reijo Sund; Eero Pukkala; Mika Gissler; Arto Leminen
Parity, tubal sterilization, hysterectomy and risk of primary fallopian tube carcinoma in Finland, 1975-2004.
International journal of cancer. Journal international du cancer 2007;120(6):1351-4.
2007: Laura Renkonen-Sinisalo; Ralf Bützow; Arto Leminen; Pentti Lehtovirta; Jukka-Pekka Mecklin; Heikki J Järvinen
Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome.
International journal of cancer. Journal international du cancer 2007;120(4):821-4.
2007: Riitta Koivisto-Korander; Arto Leminen; Oskari Heikinheimo
Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma.
Obstetrics and gynecology 2007;109(2 Pt2):512-4.
2007: Annika Riska; Arto Leminen
Updating on primary fallopian tube carcinoma.
Acta obstetricia et gynecologica Scandinavica 2007;86(12):1419-26.
2007: Salla Kumpulainen; Tapio Kuoppala; Arto Leminen; Marja Komulainen; Ulla Puistola; Risto Sankila; Juha Mäkinen; Seija Grénman
Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland.
Acta obstetricia et gynecologica Scandinavica 2007;86(5):610-4.
2006: Seija Grénman; Tom Wiklund; Jyrki Jalkanen; Tapio Kuoppala; Johanna Mäenpää; Arja Kuronen; Arto Leminen; Ulla Puistola; Päivi Vuolo-Merilä; Tuula Salmi; Maarit Vuento; Merja Yliskoski; Maija Itälä; Hans Helenius; Heikki Joensuu; Pentti Lehtovirta
A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study.
European journal of cancer (Oxford, England : 1990) 2006;42(14):2196-9.
2006: Annika Riska; Patrik Finne; Henrik Alfthan; T Anttila; Jyrki Jalkanen; T Sorvari; Ulf-Hakan Stenman; Jorma Paavonen; Arto Leminen
Past chlamydial infection is not associated with primary fallopian tube carcinoma.
European journal of cancer (Oxford, England : 1990) 2006;42(12):1835-8.
2006: Catarina Svarvar; Marcelo L Larramendy; Carl Blomqvist; Massimiliano Gentile; Riitta Koivisto-Korander; Arto Leminen; Ralf Bützow; Tom Böhling; Sakari Knuutila
Do DNA copy number changes differentiate uterine from non-uterine leiomyosarcomas and predict metastasis?
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(8):1068-82.
2006: Heini Lassus; Harri Sihto; Arto Leminen; Heikki Joensuu; Jorma Isola; Nina N Nupponen; Ralf Butzow
Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma.
Journal of molecular medicine (Berlin, Germany) 2006;84(8):671-81.
2006: Salla Kumpulainen; Tapio Kuoppala; Arto Leminen; Jorma Penttinen; Ulla Puistola; Eero Pukkala; Risto Sankila; Juha Mäkinen; Seija Grénman
Surgical treatment of ovarian cancer in different hospital categories--a prospective nation-wide study in Finland.
European journal of cancer (Oxford, England : 1990) 2006;42(3):388-95.
2006: Arto Leminen
[Not Available].
Duodecim; lääketieteellinen aikakauskirja 2006;122(19):2394-400.
2006: Annika Riska; Henrik Alfthan; Patrik Finne; Jyrki Jalkanen; T Sorvari; Ulf-Hakan Stenman; Arto Leminen
Preoperative serum hCGbeta as a prognostic marker in primary fallopian tube carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(1):43-9.
2006: Sakari Vanharanta; Patrick J Pollard; Heli J Lehtonen; Päivi Laiho; Jari Sjöberg; Arto Leminen; Kristiina Aittomäki; Johanna Arola; Mogens Kruhoffer; Torben F Orntoft; Ian P M Tomlinson; Maija Kiuru; Diego Arango; Lauri A Aaltonen
Distinct expression profile in fumarate-hydratase-deficient uterine fibroids.
Human molecular genetics 2006;15(1):97-103.
2005: Mikko Anttonen; Leila Unkila-Kallio; Arto Leminen; Ralf Butzow; Markku Heikinheimo
High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.
The Journal of clinical endocrinology and metabolism 2005;90(12):6529-35.
2005: Susanna Mannisto; Ralf Butzow; Jonna Salonen; Arto Leminen; Oskari Heikinheimo; Markku Heikinheimo
Transcription factors GATA-4 and GATA-6, and their potential downstream effectors in ovarian germ cell tumors.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(5):265-73.
2005: Mikko Loukovaara; Eero Pukkala; Pentti Lehtovirta; Arto Leminen
Epidemiology of hydatidiform mole in Finland, 1975 to 2001.
European journal of gynaecological oncology 2005;26(2):207-8.
2004: Heini Lassus; Harri Sihto; Arto Leminen; Stig Nordling; Heikki Joensuu; Nina N Nupponen; Ralf Butzow
Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma.
British journal of cancer 2004;91(12):2048-55.
2004: Annukka Paju; Juhani Vartiainen; Caj Haglund; Outi Itkonen; Kristina von Boguslawski; Arto Leminen; Torsten Wahlström; Ulf-Hakan Stenman
Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4761-8.
2004: Mehdi Benchekroun; Juli DeGraw; Jane Gao; Li Sun; Kristina von Boguslawsky; Arto Leminen; Leif C Andersson; Marja Heiskala
Impact of fixative on recovery of mRNA from paraffin-embedded tissue.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2004;13(2):116-25.
2004: Oskari Heikinheimo; Arto Leminen; Bruno Cacciatore; Eeva-Marja Rutanen; Pauli Kajanoja
Advanced cervical pregnancy: uterus-sparing therapy initiated with a combination of methotrexate and mifepristone followed by evacuation and local hemostatic measures.
Acta obstetricia et gynecologica Scandinavica 2004;83(2):211-3.
2004: Tiina-Liisa Erkinheimo; Heini Lassus; Patrik Finne; Bastiaan P van Rees; Arto Leminen; Olavi Ylikorkala; Caj Haglund; Ralf Butzow; Ari Ristimäki
Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):538-45.
2004: Mikko Loukovaara; Eero Pukkala; Pentti Lehtovirta; Arto Leminen
Epidemiology of choriocarcinoma in Finland, 1953 to 1999.
Gynecologic oncology 2004;92(1):252-5.
2004: Heini Lassus; Arto Leminen; Aki Vayrynen; Guojun Cheng; Jan-�ke GUSTAFSSON; Jorma Isola; Ralf Butzow
ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma.
Gynecologic oncology 2004;92(1):31-9.
2003: Heini Lassus; Arto Leminen; Johan Lundin; Pentti Lehtovirta; Ralf Butzow
Distinct subtypes of serous ovarian carcinoma identified by p53 determination.
Gynecologic oncology 2003;91(3):504-12.
2003: Erik Mandelin; Heini Lassus; Markku Seppala; Arto Leminen; Jan-�ke GUSTAFSSON; Guojun Cheng; Ralf Bützow; Riitta Koistinen
Glycodelin in ovarian serous carcinoma: association with differentiation and survival.
Cancer research 2003;63(19):6258-64.
2003: Jarna Moilanen; Heini Lassus; Arto Leminen; Antti Vaheri; Ralf Bützow; Olli Carpén
Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients.
Gynecologic oncology 2003;90(2):273-81.
2003: Annika Riska; Arto Leminen; Eero Pukkala
Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953-97.
International journal of cancer. Journal international du cancer 2003;104(5):643-5.
2003: Oskari Heikinheimo; Arto Leminen
[Oral contraceptive and the increased risk of cervical cancer].
Duodecim; lääketieteellinen aikakauskirja 2003;119(24):2405-6.
2003: M Stenman; Annukka Paju; roeland hanemaaijer; Taina Tervahartiala; Arto Leminen; Ulf-Hakan Stenman; Y T Konttinen; T Sorsa
Collagenases (MMP-1, -8 and -13) and trypsinogen-2 in fluid from benign and malignant ovarian cysts.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(1):9-12.
2001: Annukka Paju; Timo Sorsa; Taina Tervahartiala; Erkki Koivunen; Caj Haglund; Arto Leminen; Torsten Wahlström; Tuula Salo; Ulf-Hakan Stenman
The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
British journal of cancer 2001;84(10):1363-71.
2000: Arto Leminen
Comparison between personal learning curves for abdominal and laparoscopic hysterectomy.
Acta obstetricia et gynecologica Scandinavica 2000;79(12):1100-4.
2000: Arto Leminen; M Forss; Jorma Paavonen
Wound complications in patients with carcinoma of the vulva. Comparison between radical and modified vulvectomies.
European journal of obstetrics, gynecology, and reproductive biology 2000;93(2):193-7.
2000: Leila Unkila-Kallio; Aila Tiitinen; Torsten Wahlström; Pentti Lehtovirta; Arto Leminen
Reproductive features in women developing ovarian granulosa cell tumour at a fertile age.
Human reproduction (Oxford, England) 2000;15(3):589-93.
1999: Arto Leminen; Pentti Lehtovirta
Spread of ovarian cancer after laparoscopic surgery: report of eight cases.
Gynecologic oncology 1999;75(3):387-90.
1999: Arto Leminen; Pentti Lehtovirta
[Is cancer spreading during laparoscopy?].
Duodecim; lääketieteellinen aikakauskirja 1999;115(7):745-6.
1998: Leila Unkila-Kallio; Arto Leminen; Aila Tiitinen; Olavi Ylikorkala
Nationwide data on falling incidence of ovarian granulosa cell tumours concomitant with increasing use of ovulation inducers.
Human reproduction (Oxford, England) 1998;13(1O):2828-30.
1998: P Venesmaa; Ulf-Hakan Stenman; M Forss; Arto Leminen; Pentti Lehtovirta; Juhani Vartiainen; Jorma Paavonen
Pre-operative serum level of tumour-associated trypsin inhibitor and residual tumour size as prognostic indicators in Stage III epithelial ovarian cancer.
British journal of obstetrics and gynaecology 1998;105(5):508-11.
1998: Arto Leminen; M Koivistoinen; Jari Sjöberg
[Prolapsed vagina after hysterectomy--treatment methods and their effectiveness].
Duodecim; lääketieteellinen aikakauskirja 1998;114(9):861-4.
1997: Leila Unkila-Kallio; Arto Leminen; A Tiitnen; Pentti Lehtovirta; Torsten Wahlström; Olavi Ylikorkala
Malignant tumors of the ovary or the breast in association with infertility: a report of thirteen cases.
Acta obstetricia et gynecologica Scandinavica 1997;76(2):177-81.
1995: R Sumoi; T Hakala-Ala-Pietilä; Arto Leminen; Jukka-Pekka Mecklin; Pentti Lehtovirta
Hereditary aspects of endometrial adenocarcinoma.
International journal of cancer. Journal international du cancer 1995;62(2):132-7.
1995: Arto Leminen; M Forss; Pentti Lehtovirta
Therapeutic and prognostic considerations in primary carcinoma of the vagina.
Acta obstetricia et gynecologica Scandinavica 1995;74(5):379-83.
1995: Arto Leminen; M Forss; Pentti Lehtovirta
Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors.
Acta obstetricia et gynecologica Scandinavica 1995;74(1):61-6.
1994: P Venesmaa; Pentti Lehtovirta; Ulf-Hakan Stenman; Arto Leminen; M Forss; Olavi Ylikorkala
Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancer.
British journal of cancer 1994;70(6):1188-90.
1993: P J Mäkelä; Arto Leminen; M Kääriäinen; Pentti Lehtovirta
Pretreatment sonographic evaluation of inguinal lymph nodes in patients with vulvar malignancy.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 1993;12(5):255-8.
1992: Matti Lehtinen; Arto Leminen; T Kuoppala; M Tiikkainen; T Lehtinen; Pentti Lehtovirta; Reijo Punnonen; E Vesterinen; Jorma Paavonen
Pre- and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma.
Journal of medical virology 1992;37(3):180-6.
1992: Matti Lehtinen; Arto Leminen; Jorma Paavonen; Pentti Lehtovirta; Heikki Hyöty; E Vesterinen; J Dillner
Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma.
Journal of clinical pathology 1992;45(6):494-7.
1992: Arto Leminen; H Alftan; Ulf-Hakan Stenman; Pentti Lehtovirta
Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response.
Acta obstetricia et gynecologica Scandinavica 1992;71(4):293-7.
1991: Arto Leminen; Jorma Paavonen; E Vesterinen; Torsten Wahlström; I Rantala; Matti Lehtinen
Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix.
American journal of clinical pathology 1991;95(5):647-52.
1990: Arto Leminen
Tumor markers CA 125, carcinoembryonic antigen and tumor-associated trypsin inhibitor in patients with cervical adenocarcinoma.
Gynecologic oncology 1990;39(3):358-63.
1990: Arto Leminen; Jorma Paavonen; E Vesterinen; M Forss; Torsten Wahlström; P Kulomaa; Matti Lehtinen
Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction.
American journal of obstetrics and gynecology 1990;162(3):848-53.
1990: Arto Leminen; Jorma Paavonen; M Forss; Torsten Wahlström; E Vesterinen
Adenocarcinoma of the uterine cervix.
Cancer 1990;65(1):53-9.
1989: Arto Leminen; Jorma Paavonen; M Forss; T Wahlström; E Vesterinen
[Cervical adenocarcinoma--still a diagnostic and therapeutic problem].
Duodecim; lääketieteellinen aikakauskirja 1989;105(9):846-50.